the aid library

LIST OPTIONS

Filter

495

Mettre en œuvre des programmes complets de lutte contre le VIH et les IST auprès des hommes ayant des rapports sexuels avec des hommes

J. Bear; G. Ayala; J. Butler; et al. Fonds des Nations Unies pour la population; Organisation mondiale de la Santé; UNAIDS; USAID; et al. (2015) C2

Approaches pratiques pour des interventions collaboratives

External Link

The malaria testing and treatment landscape in Benin

Zinsou, C.; A. Bello Cherifath ACT Watch Group et al (2017) C1

Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to investigate the availability, price, and market share of... more

Download (158)

View PDF (223)

COVID-19 natural immunity

World Health Organization WHO (2021) C_WHO

10 May 2021 This scientific brief replaces the WHO Scientific Brief entitled “’Immunity passports’ in the context of COVID-19”, published 24 April 2020. This update is focused on what is currently understood about SARS-CoV-2 immunity from natural infection. More information about considera... more

Download (658)

View PDF (407)

Essential Medicines List for Management of Patients Admitted to Intensive Care Units with Suspected or Confirmed COVID-19 Diagnosis
recommended

World Health Organization WHO (2020) C_WHO

Updated 10 August 2020 This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent... more

Download (106)

View PDF (158)

Imunidade natural contra a COVID-19 Informe científico 10 de maio de 2021

Organização Mundial da Saúde (OMS) OPAS, OMS (2021) C_WHO

Natural immunity against COVID-19 Scientific report 10 May 2021

Download (114)

View PDF (121)

Development Co-operation Report 2020

OECD (2020) CC

The annual Development Co-operation Report brings new evidence, analysis and ideas on sustainable development to members of the OECD Development Assistance Committee (DAC) and the international community more broadly. The objectives are to promote best practices and innovation in development co-ope... more

Download (1424)

View PDF (3068)

Tuberculosis. Practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries

Médecins sans Frontières MSF (2022) C2

This Tuberculosis guide has been developed jointly by Médecins Sans Frontières and Partners In Health. It aims at providing useful information to the clinicians and health staff for the comprehensive management of tuberculosis. Forms of susceptible and resistant tuberculosis, tuberculosis in child... more

Download (2328)

View PDF (1956)

Turn Down The Heat

The World Bank (2012) CC

Why a 4°C warmer world must be avoided

Download (353)

View PDF (640)

Safety and security for national humanitarian workers

Stoddard, Abby ; Harmer, Adele ; Haver, Katherine Office for the Coordination of Humanitarian Affairs (OCHA) (2011) C1

Annex I to: To stay and deliver, good practice for humanitarians in complex security environments

The principal findings of the report include that despite overall improvements in aid agencies’ security risk management, national aid workers perceive continued inequities in security suppor... more

Download (240)

View PDF (406)

Crackdown on Dissent. Brutality, Torture, and Political Persecution in Venezuela

Human Rights Watch (2018) C1

Download (117)

View PDF (161)

Drug Regulation in Kenya

LEAP (2021) CC

Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

External Link

Smart and Sustainable Cities: The Main Guidelines of City Statute for Increasing the Intelligence of Brazilian Cities

E. G. Lima, Chinelli C. K., Azevedo Guedes A. L., et al. (2020) CC

Sustainability 2020, 12, 1025

External Link

Geographical, landscape and host associations of Trypanosoma cruzi DTUs and lineages

Izeta-Alberdi, A.; Ibarra-Cerdena, C.; Moo-llanes, D.; Ramsey,J. BMC Part of Springer Nature (2016) CC

Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio... more

Download (228)

View PDF (242)

Communicating with caregivers about the Human Papillomavirus vaccination

World Health Organisation (WHO) (2023) C_WHO

This training module is designed to equip health workers (HWs) with knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus (HPV) vaccine.

Essential Medicines List for Management of Patients Admitted to Intensive Care Units with Suspected or Confirmed COVID-19 Diagnosis recommended

Essential Medicines List for Management of Patients Admitted to Intensive Care Units with Suspected or Confirmed COVID-19 Diagnosis
recommended